A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
Genetic and clinical evidence suggests omega-3 fatty acids may modestly lower diabetic kidney disease risk and improve related markers like triglycerides and blood pressure, but not overall kidney filtering function.
High-dose omega-3s (>1500 mg/day) were linked to higher atrial fibrillation risk only in people already at high cardiovascular risk, while lower doses showed no increased risk.
High-dose (≥1,200 mg/day) early-life omega-3 supplementation was linked to a lower risk of childhood asthma/wheezing, with each extra 1,000 mg/day associated with about a 26% risk reduction.
Omega-3 supplementation significantly raised blood levels of two precursor compounds linked to the body's natural inflammation-resolving pathways, especially in people with existing inflammatory or metabolic conditions.
In hemodialysis patients, omega-3 supplementation was linked to fewer cardiovascular deaths, heart attacks, and vascular access complications, but not a reduction in overall mortality.